Ethris
Planegg, DE
Hybrid — also manufactures internal programs
Program data pending ClinicalTrials.gov matching
· Last scored 2026-10-29
56.5
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (1)
○ EMA GMP
○ MHRA GMP
Quick Facts: Ethris
- Signal Score
- 56.5/100 (as of 2026-10-29)
- Quality Compliance
- Assessment pending
- Headquarters
- Planegg, DE
- Modalities
- mRNA
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Ethris
Hybrid developer + CDMO.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesmRNA
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
53.0
1 manufacturing site: Planegg, DE
Modalities: mRNA
Capacity assessment: 53.0/100
Sites: Planegg, DE
Source: company profiles (manufacturing sites, modality breadth)
1 manufacturing site
Press Signals1 articles (not scored)
1 manufacturing site: Planegg, DE
Modalities: mRNA
Capacity assessment: 53.0/100
Hiring Activity Beta
From public job postings on Ethris' careers board, as of Nov 20, 2026. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No open roles were listed on Nov 20, 2026.
Coverage: counted from Ethris' own careers board.
Function groups come mainly from job titles (about 84% match a hand check), and modality words from titles only, so both are approximate.
Source:
personio
· Checked Nov 20, 2026 · Tracking since Oct 26, 2026
Company Signals 1 articles
Company announcements, not verified evidence. They do not change any score.
Thermo Fisher, Ethris Partner to Offer Integrated mRNA Solutions for Biopharma - MSN
Thermo Fisher, Ethris Partner to Offer Integrated mRNA Solutions for Biopharma MSN
Frequently Asked Questions About Ethris
What is Ethris's CDMO Signal Score?
Ethris has a Signal Score of 56/100, based on quality, operations, financial stability, and capacity data.
Evaluating Ethris for a manufacturing program?
Use the free AI matchmaker to compare Ethris against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Corden Pharma
Plankstadt, DE · Caponago, IT · Boulder, CO
Signal Score: 83.1
mRNA, Oligonucleotide, Biologics
Wacker Biotech
Jena, DE · Amsterdam, NL · San Diego, CA
Signal Score: 82.9
Recombinant Protein, Plasmid DNA, mRNA, Microbial Fermentation
BioNTech (Mfg Services)
Mainz, DE · Marburg, DE
Signal Score: 82.1
mRNA
Merck KGaA / MilliporeSigma (CDMO)
Darmstadt, DE · St. Louis, MO
Signal Score: 81.9
mRNA, Biologics, Cell Therapy
CureVac (CDMO Services)
Tubingen, DE
Signal Score: 75.3
mRNA
Compare Ethris with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.